Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology

Table 2 Treatment modalities and Outcomes of non metastatic patients

	N. of patients	(%)
Surgery	145
Radical mastectomy	104	72
Conservative surgery	41	28
Chemotherapy
Neoadjuvant chemotherapy	14	10
pCR	4	28
Adjuvant chemotherapy	131	90
Anthracycline based regimens	99	75
Sequentiel anthracycline taxane	27	20
Taxane alone	4	5
Outcomes
Overall survival at 5 years		79,7
Stade I		92,3
Stade II		86,5
Stade III		57,8
Disease free survival at 5 years		77,8

ISSN: 1472-6874